Dopamine D3 partial agonists in the treatment of psychosis and substance use disorder comorbidity: a pharmacological alternative to consider?

被引：4
|
作者：
Hernandez-Huerta, Daniel [1 ]
Morillo-Gonzalez, Jessenia [1 ]
机构：
[1] Ramon y Cajal Univ Hosp, Dept Psychiat, Madrid, Spain
来源：
CNS SPECTRUMS | 2021年 / 26卷 / 05期
关键词：
D O I：
10.1017/S1092852920001510
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：444 / 445
页数：2
相关论文
共 50 条
  • [1] ARYLPIPERAZINYLPROPOXYPHENYLBENZIMIDAZOLES AS DOPAMINE D3 PARTIAL AGONISTS
    WRIGHT, JL
    DOWNING, DM
    HEFFNER, TG
    PUGSLEY, TA
    MACKENZIE, RG
    WISE, LD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 131 - MEDI
  • [2] Dopamine D3 receptor agonists as pharmacological tools
    Kassel, S.
    Schwed, J. S.
    Stark, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (09) : 1480 - 1499
  • [3] The role of the D3 dopamine receptor and its partial agonist cariprazine in patients with schizophrenia and substance use disorder
    Grunze, Heinz
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 1985 - 1992
  • [4] Dopamine D1 and D3 receptor polypharmacology as a potential treatment approach for substance use disorder
    Galaj, Ewa
    Ewing, Scott
    Ranaldi, Robert
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2018, 89 : 13 - 28
  • [5] Dopamine in Autism Spectrum Disorders-Focus on D2/D3 Partial Agonists and Their Possible Use in Treatment
    Mandic-Maravic, Vanja
    Grujicic, Roberto
    Milutinovic, Luka
    Munjiza-Jovanovic, Ana
    Pejovic-Milovancevic, Milica
    FRONTIERS IN PSYCHIATRY, 2022, 12
  • [6] Dopamine D3 Agonists in the Treatment of Parkinson's Disease
    Das, Banibrata
    Modi, Gyan
    Dutta, Aloke
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (10) : 908 - 926
  • [7] Functionally Selective Dopamine D2, D3 Receptor Partial Agonists
    Moeller, Dorothee
    Kling, Ralf C.
    Skultety, Marika
    Leuner, Kristina
    Huebner, Harald
    Gmeiner, Peter
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (11) : 4861 - 4875
  • [8] Dopamine D3 receptor as a new pharmacological target for the treatment of depression
    Leggio, Gian Marco
    Salomone, Salvatore
    Bucolo, Claudio
    Platania, Chiara
    Micale, Vincenzo
    Caraci, Filippo
    Drag, Filippo
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 719 (1-3) : 25 - 33
  • [9] Novel and highly selective dopamine D3 receptor antagonists/partial agonists as potential treatments for opioid use disorders
    Shaik, Anerbasha
    Bonifazi, Alessandro
    Cemaj, Sophie
    Giancola, JoLynn
    Gadiano, Alexandra
    Rais, Rana
    Slusher, Barbara
    Newman, Amy
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [10] The position statement of the Working Group of the Polish Psychiatric Association on the use of D2/D3 dopamine receptor partial agonists in the treatment of mental disorders
    Wichniak, Adam
    Samochowiec, Jerzy
    Szulc, Agata
    Dudek, Dominika
    Heitzman, Janusz
    Janas-Kozik, Malgorzata
    Wolanczyk, Tomasz
    Rymaszewska, Joanna
    Siwek, Marcin
    Bienkowski, Przemyslaw
    PSYCHIATRIA POLSKA, 2021, 55 (05) : 941 - 966
12345